PROK,ProKidney Corp. | Healthcare

Healthcare

PROK

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

ProKidney Corp.PROK

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

ProKidney Corp., a clinical-stage biotechnology company, provides transformative proprietary cell therapy platform for treating various chronic kidney diseases.

The company's lead product is Renal Autologous Cell Therapy (REACT), an autologous homologous cell admixture that is in Phase I for REACT in patients with Congenital Anomalies of the Kidney and Urinary Tract (CAKUT), as well as in Phase III and Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease.

ProKidney Corp. founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Latest News >

Hudson Technologies Swings to Q4 Net Loss, Revenue Decreases -- Shares Fall After Hours

Mar 6, 2025

05:07 PM EST, 03/06/2025 (MT Newswires) -- Hudson Technologies ( HDSN ) reported a Q4 net loss Thursday of $0x per diluted share, compared with net income of $0.08 a year earlier. Four analysts polled by FactSet expected a loss of $0.03. Revenue for the quarter ended Dec. 31 was $34.6 million, down from $44.9 million a year earlier. Four...

Funko Reports Q4 Adjusted Earnings on Higher Sales; Sets Guidance; Shares Fall After Hours

Mar 6, 2025

05:08 PM EST, 03/06/2025 (MT Newswires) -- Funko ( FNKO ) reported Q4 adjusted earnings late Thursday of $0.08 per diluted share, compared with breaking even a year earlier. Two analysts polled by FactSet expected the company to break even. Net sales for the quarter that ended Dec. 31 was $293.7 million, up from $291.2 million a year earlier. Two...

Castellum Insider Sold Shares Worth $710,275, According to a Recent SEC Filing

Mar 6, 2025

05:07 PM EST, 03/06/2025 (MT Newswires) -- Mark C Fuller, 10% Owner, Director, on March 05, 2025, sold 500,000 shares in Castellum (CTM) for $710,275. Following the Form 4 filing with the SEC, Fuller has control over a total of 7,113,659 common shares of the company, with 7,113,659 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1877939/000194454425000010/xslF345X05/wk-form4_1741298609.xml ...

American Outdoor Brands Fiscal Q3 Profit, Revenue Rise

Mar 6, 2025

05:05 PM EST, 03/06/2025 (MT Newswires) -- American Outdoor Brands ( AOUT ) reported fiscal Q3 non-GAAP diluted earnings Thursday of $0.21 per share, up from $0.08 a year earlier. Two analysts polled by FactSet expected $0.09. Revenue in the three months ended Jan. 31 rose to $58.5 million from $53.4 million a year earlier. Two analysts surveyed by FactSet...